Wave Total Assets from 2010 to 2024

WVE Stock

USD 14.27 0.08 0.56%

Wave Life's Total Assets are increasing over the years with slightly volatile fluctuation. Total Assets are expected to dwindle to about 200.5 M. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2013-12-31

Previous Quarter

208.8 M

Current Value

358.5 M

Quarterly Volatility

95.9 M

Yuan Drop

Covid

Check Wave Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Wave Life's main balance sheet or income statement drivers, such as Depreciation And Amortization of 9.7 M, Interest Expense of 1.8 M or Selling General Administrative of 33.7 M, as well as many indicators such as Price To Sales Ratio of 4.49, Dividend Yield of 0.0 or PTB Ratio of 16.29. Wave financial statements analysis is a perfect complement when working with Wave Life Valuation or Volatility modules.

Check out the analysis of Wave Life Correlation against competitors.

Latest Wave Life's Total Assets Growth Pattern

Below is the plot of the Total Assets of Wave Life Sciences over the last few years. Total assets refers to the total amount of Wave Life assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Wave Life Sciences books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Wave Life's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Wave Life's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 274.95 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Wave Total Assets Regression Statistics

	Arithmetic Mean	147,505,927
	Geometric Mean	48,019,639
	Coefficient Of Variation	78.50
	Mean Deviation	96,855,941
	Median	165,424,000
	Standard Deviation	115,786,017
	Sample Variance	13406.4T
	Range	293.6M
	R-Value	0.79
	Mean Square Error	5323.6T
	R-Squared	0.63
	Significance	0.0004
	Slope	20,570,726
	Total Sum of Squares	187689.6T

Wave Total Assets History

	2024	200.5 M
	2023	274.9 M
	2022	146.4 M
	2021	207 M
	2020	279.2 M
	2019	284.2 M
	2018	295.9 M

Other Fundumenentals of Wave Life Sciences

Intangibles To Total Assets

Wave Life Total Assets component correlations

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Property Plant Equipment	Net Tangible Assets	Deferred Long Term Liab	Short Long Term Debt	Long Term Debt Total	Capital Surpluse	Net Invested Capital	Net Working Capital	Long Term Investments	Capital Stock
Total Assets		0.56	0.74	-0.9	-0.67	0.83	0.69	0.85	0.98	-0.12	0.79	0.84	0.39	-0.5	-0.52	-0.86	0.61	-0.55	-0.61	-0.26	0.54
Total Stockholder Equity	0.56		0.1	-0.77	0.08	0.15	0.21	0.03	0.65	-0.64	0.1	0.31	0.9	-0.32	0.21	-0.36	-0.11	0.27	0.2	-0.01	-0.17
Current Deferred Revenue	0.74	0.1		-0.64	-0.79	0.68	0.87	0.8	0.7	0.39	0.69	0.64	-0.23	-0.26	-0.63	-0.66	0.81	-0.6	-0.74	-0.73	0.71
Net Debt	-0.9	-0.77	-0.64		0.54	-0.65	-0.58	-0.59	-0.95	0.2	-0.63	-0.61	-0.53	0.49	0.27	0.77	-0.52	0.35	0.4	0.41	-0.42
Retained Earnings	-0.67	0.08	-0.79	0.54		-0.83	-0.62	-0.84	-0.64	-0.54	-0.94	-0.54	0.31	0.31	0.71	0.76	-0.99	0.91	0.87	0.57	-0.96
Accounts Payable	0.83	0.15	0.68	-0.65	-0.83		0.59	0.9	0.78	0.15	0.89	0.71	0.04	-0.37	-0.69	-0.86	0.77	-0.83	-0.83	-0.24	0.71
Net Receivables	0.69	0.21	0.87	-0.58	-0.62	0.59		0.69	0.68	0.25	0.59	0.63	-0.04	-0.23	-0.54	-0.56	0.61	-0.38	-0.5	-0.53	0.57
Total Liab	0.85	0.03	0.8	-0.59	-0.84	0.9	0.69		0.76	0.25	0.89	0.82	-0.09	-0.41	-0.75	-0.8	0.78	-0.83	-0.85	-0.26	0.74
Total Current Assets	0.98	0.65	0.7	-0.95	-0.64	0.78	0.68	0.76		-0.13	0.78	0.73	0.45	-0.53	-0.41	-0.83	0.59	-0.48	-0.52	-0.29	0.55
Short Term Debt	-0.12	-0.64	0.39	0.2	-0.54	0.15	0.25	0.25	-0.13		0.33	-0.14	-0.79	0.11	-0.38	-0.04	0.59	-0.47	-0.42	-0.54	0.64
Common Stock	0.79	0.1	0.69	-0.63	-0.94	0.89	0.59	0.89	0.78	0.33		0.62	-0.06	-0.42	-0.66	-0.82	0.88	-0.86	-0.81	-0.32	0.91
Property Plant Equipment	0.84	0.31	0.64	-0.61	-0.54	0.71	0.63	0.82	0.73	-0.14	0.62		0.25	-0.24	-0.7	-0.78	0.46	-0.5	-0.59	-0.11	0.35
Net Tangible Assets	0.39	0.9	-0.23	-0.53	0.31	0.04	-0.04	-0.09	0.45	-0.79	-0.06	0.25		-0.3	0.31	-0.2	-0.38	0.37	0.39	0.4	-0.4
Deferred Long Term Liab	-0.5	-0.32	-0.26	0.49	0.31	-0.37	-0.23	-0.41	-0.53	0.11	-0.42	-0.24	-0.3		-0.24	0.13	-0.26	0.37	0.34	-0.01	-0.29
Short Long Term Debt	-0.52	0.21	-0.63	0.27	0.71	-0.69	-0.54	-0.75	-0.41	-0.38	-0.66	-0.7	0.31	-0.24		0.74	-0.68	0.66	0.65	0.31	-0.61
Long Term Debt Total	-0.86	-0.36	-0.66	0.77	0.76	-0.86	-0.56	-0.8	-0.83	-0.04	-0.82	-0.78	-0.2	0.13	0.74		-0.72	0.67	0.67	0.32	-0.62
Capital Surpluse	0.61	-0.11	0.81	-0.52	-0.99	0.77	0.61	0.78	0.59	0.59	0.88	0.46	-0.38	-0.26	-0.68	-0.72		-0.88	-0.87	-0.69	0.95
Net Invested Capital	-0.55	0.27	-0.6	0.35	0.91	-0.83	-0.38	-0.83	-0.48	-0.47	-0.86	-0.5	0.37	0.37	0.66	0.67	-0.88		0.93	0.34	-0.85
Net Working Capital	-0.61	0.2	-0.74	0.4	0.87	-0.83	-0.5	-0.85	-0.52	-0.42	-0.81	-0.59	0.39	0.34	0.65	0.67	-0.87	0.93		0.46	-0.78
Long Term Investments	-0.26	-0.01	-0.73	0.41	0.57	-0.24	-0.53	-0.26	-0.29	-0.54	-0.32	-0.11	0.4	-0.01	0.31	0.32	-0.69	0.34	0.46		-0.54
Capital Stock	0.54	-0.17	0.71	-0.42	-0.96	0.71	0.57	0.74	0.55	0.64	0.91	0.35	-0.4	-0.29	-0.61	-0.62	0.95	-0.85	-0.78	-0.54

Click cells to compare fundamentals

About Wave Life Financial Statements

Wave Life stakeholders use historical fundamental indicators, such as Wave Life's Total Assets, to determine how well the company is positioned to perform in the future. Although Wave Life investors may analyze each financial statement separately, they are all interrelated. For example, changes in Wave Life's assets and liabilities are reflected in the revenues and expenses on Wave Life's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Wave Life Sciences. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Total Assets	274.9 M	200.5 M
Intangibles To Total Assets	(0.03)	(0.03)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

When determining whether Wave Life Sciences is a strong investment it is important to analyze Wave Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Wave Life's future performance. For an informed investment choice regarding Wave Stock, refer to the following important reports:

How To Invest In Wave

Details

Is Wave Stock a good investment?

Details

What is Wave Life's Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out the analysis of Wave Life Correlation against competitors.

You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Wave Life. If investors know Wave will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Wave Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.12)

Revenue Per Share

0.427

Quarterly Revenue Growth

(0.11)

Return On Assets

(0.34)

Return On Equity

(2.44)

The market value of Wave Life Sciences is measured differently than its book value, which is the value of Wave that is recorded on the company's balance sheet. Investors also form their own opinion of Wave Life's value that differs from its market value or its book value, called intrinsic value, which is Wave Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Wave Life's market value can be influenced by many factors that don't directly affect Wave Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Wave Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Wave Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Wave Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Wave Total Assets from 2010 to 2024

Latest Wave Life's Total Assets Growth Pattern

Wave Total Assets Regression Statistics

Wave Total Assets History

Other Fundumenentals of Wave Life Sciences

Wave Life Total Assets component correlations

About Wave Life Financial Statements

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY